PRVB insider filings

Provention Bio, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-04-28. Screen PRVB transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for PRVB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Provention Bio, Inc.

FiledFormInsiderReported transactionsSource
2023-04-284Sessa Capital (Master), L.P. — 10% owner
Sessa Capital GP, LLC — 10% owner
Sessa Capital IM, L.P. — 10% owner
Sessa Capital IM GP, LLC — 10% owner
Petry John — 10% owner
Code (U): 15,567,497EDGAR
2023-04-274Pisano Wayne — DirectorCode (U): 7,500 · Disposition to issuer (D): 128,981 (derivative) · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 22,200 (derivative) · Disposition to issuer (D): 23,000 (derivative) · Disposition to issuer (D): 33,000 (derivative)EDGAR
2023-04-274Jenkins John Kenneth — DirectorDisposition to issuer (D): 128,981 (derivative) · Disposition to issuer (D): 23,000 (derivative) · Disposition to issuer (D): 33,000 (derivative)EDGAR
2023-04-274Jain Rita — DirectorDisposition to issuer (D): 66,000 (derivative)EDGAR
2023-04-274Yi Miyoko Christina — Chief Operations OfficerDisposition to issuer (D): 300,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 187,000 (derivative)EDGAR
2023-04-274Leon Francisco — Chief Scientific OfficerCode (U): 73,000 · Code (U): 1,500,000 · Code (U): 1,000,000 · Disposition to issuer (D): 242,103 (derivative) · Disposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 137,750 (derivative) · +3 moreEDGAR
2023-04-274Osorio Benedict — Chief Quality OfficerDisposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 70,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 187,000 (derivative)EDGAR
2023-04-274Hoitt Jason — Chief Commercial OfficerDisposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 137,750 (derivative) · Disposition to issuer (D): 139,500 (derivative) · Disposition to issuer (D): 145,000 (derivative) · Disposition to issuer (D): 200,000 (derivative)EDGAR
2023-04-274King-Jones Heidy — Chief Legal OfficerDisposition to issuer (D): 300,000 (derivative) · Disposition to issuer (D): 139,500 (derivative) · Disposition to issuer (D): 145,000 (derivative) · Disposition to issuer (D): 200,000 (derivative)EDGAR
2023-04-274Chauche Thierry — Chief Financial OfficerDisposition to issuer (D): 375,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 200,000 (derivative)EDGAR
2023-04-274Vogel Justin — Chief Accounting OfficerDisposition to issuer (D): 88,185 (derivative) · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 66,000 (derivative) · Disposition to issuer (D): 70,000 (derivative) · Disposition to issuer (D): 84,000 (derivative)EDGAR
2023-04-274Palmer Ashleigh — Director and CEOCode (U): 2,570,050 · Disposition to issuer (D): 441,720 (derivative) · Disposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 137,750 (derivative) · Disposition to issuer (D): 139,500 (derivative) · Disposition to issuer (D): 360,000 (derivative) · +1 moreEDGAR
2023-04-274Ramos Eleanor — Chief Medical OfficerCode (U): 70,000 · Disposition to issuer (D): 460,462 (derivative) · Disposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 137,750 (derivative) · Disposition to issuer (D): 139,500 (derivative) · Disposition to issuer (D): 145,000 (derivative) · +1 moreEDGAR
2023-04-274Wysenski Nancy — DirectorDisposition to issuer (D): 128,981 (derivative) · Disposition to issuer (D): 22,200 (derivative) · Disposition to issuer (D): 23,000 (derivative) · Disposition to issuer (D): 33,000 (derivative)EDGAR
2023-04-274CATLIN AVERY W — DirectorCode (U): 10,000 · Code (U): 10,000 · Disposition to issuer (D): 128,981 (derivative) · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 22,200 (derivative) · Disposition to issuer (D): 23,000 (derivative) · +1 moreEDGAR
2023-04-244Sessa Capital (Master), L.P. — 10% owner
Sessa Capital GP, LLC — 10% owner
Sessa Capital IM, L.P. — 10% owner
Sessa Capital IM GP, LLC — 10% owner
Petry John — 10% owner
Gift (G): 202,314 @ $0 · Gift (G): 224,617 @ $0EDGAR
2023-04-184Sessa Capital (Master), L.P. — 10% owner
Sessa Capital GP, LLC — 10% owner
Sessa Capital IM, L.P. — 10% owner
Sessa Capital IM GP, LLC — 10% owner
Petry John — 10% owner
Option exercise/expiry (X): 8,879,023 @ $6 · Sale (S): 2,190,549 @ $24.32 · Option exercise/expiry (X): 8,879,023 (derivative) @ $0EDGAR
2023-04-144Leon Francisco — Chief Scientific OfficerGift (G): 1,500,000 @ $0 · Gift (G): 1,500,000 @ $0EDGAR
2023-04-144CATLIN AVERY W — DirectorGift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0EDGAR
2023-04-044Sessa Capital (Master), L.P. — 10% owner
Sessa Capital GP, LLC — 10% owner
Sessa Capital IM, L.P. — 10% owner
Sessa Capital IM GP, LLC — 10% owner
Petry John — 10% owner
Other (J): 3,000,000 @ $0 · Gift (G): 218,651 @ $0EDGAR
2023-02-144Leon Francisco — Chief Scientific OfficerOption exercise (M): 50,000 @ $2.50 · Sale (S): 50,000 @ $10.11 · Option exercise (M): 25,985 @ $2.50 · Sale (S): 25,985 @ $10.04 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 25,985 (derivative) @ $0EDGAR
2023-02-144Hoitt Jason — Chief Commercial OfficerSale (S): 4,500 @ $10.00EDGAR
2023-02-144Palmer Ashleigh — Director and CEO, DirectorOption exercise (M): 50,000 @ $2.50 · Sale (S): 50,000 @ $10.11 · Option exercise (M): 25,835 @ $2.50 · Sale (S): 25,835 @ $10.04 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 25,835 (derivative) @ $0EDGAR
2023-01-204Leon Francisco — Chief Scientific OfficerOption exercise (M): 24,015 @ $2.50 · Sale (S): 24,015 @ $10.27 · Option exercise (M): 24,015 (derivative) @ $0EDGAR
2023-01-204Sessa Capital (Master), L.P. — 10% owner
Sessa Capital GP, LLC — 10% owner
Sessa Capital IM, L.P. — 10% owner
Sessa Capital IM GP, LLC — 10% owner
Petry John — 10% owner
Sale (S): 3,000,000 @ $9.40EDGAR
2023-01-204Palmer Ashleigh — Director and CEO, DirectorOption exercise (M): 24,165 @ $2.50 · Sale (S): 24,165 @ $10.27 · Option exercise (M): 24,165 (derivative) @ $0EDGAR
2023-01-184Palmer Ashleigh — Director and CEO, DirectorGrant/award (A): 700,000 (derivative) @ $0EDGAR
2023-01-114Yi Miyoko Christina — Chief Operations OfficerGrant/award (A): 21,000 (derivative) @ $0 · Grant/award (A): 187,000 (derivative) @ $0EDGAR
2023-01-114Osorio Benedict — Chief Quality OfficerGrant/award (A): 187,000 (derivative) @ $0EDGAR
2023-01-114O'Brien Sarah — Chief People OfficerGrant/award (A): 8,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-01-114Leon Francisco — Chief Scientific OfficerGrant/award (A): 210,000 (derivative) @ $0EDGAR
2023-01-114King-Jones Heidy — Chief Legal OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2023-01-114Hoitt Jason — Chief Commercial OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2023-01-114Chauche Thierry — Chief Financial OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2023-01-114Vogel Justin — Chief Accounting OfficerGrant/award (A): 84,000 (derivative) @ $0EDGAR
2023-01-114Ramos Eleanor — Chief Medical OfficerGrant/award (A): 210,000 (derivative) @ $0EDGAR
2023-01-054Jain Rita — DirectorGrant/award (A): 66,000 (derivative) @ $0EDGAR
2022-12-304Leon Francisco — Chief Scientific OfficerOption exercise (M): 187,000 @ $2.50 · Sale (S): 187,000 @ $10.26 · Option exercise (M): 187,000 (derivative) @ $0EDGAR
2022-12-294Leon Francisco — Chief Scientific OfficerOption exercise (M): 10,674 @ $2.50 · Sale (S): 10,674 @ $10 · Option exercise (M): 10,674 (derivative) @ $0EDGAR
2022-12-274Leon Francisco — Chief Scientific OfficerOption exercise (M): 1,568 @ $2.50 · Sale (S): 1,568 @ $10.00 · Option exercise (M): 375 @ $2.50 · Sale (S): 375 @ $10 · Option exercise (M): 1,568 (derivative) @ $0 · Option exercise (M): 375 (derivative) @ $0EDGAR
2022-12-094Osorio Benedict — Chief Quality OfficerGrant/award (A): 18,000 (derivative) @ $0EDGAR
2022-12-094Leon Francisco — Chief Scientific OfficerGrant/award (A): 20,663 (derivative) @ $0EDGAR
2022-12-094Yi Miyoko Christina — Chief Operations OfficerGrant/award (A): 6,000 (derivative) @ $0EDGAR
2022-12-094Hoitt Jason — Chief Commercial OfficerGrant/award (A): 120,000 (derivative) @ $0 · Grant/award (A): 20,663 (derivative) @ $0EDGAR
2022-12-094Palmer Ashleigh — Director and CEO, DirectorGrant/award (A): 20,663 (derivative) @ $0EDGAR
2022-12-094Ramos Eleanor — Chief Medical OfficerGrant/award (A): 20,663 (derivative) @ $0EDGAR
2022-11-234Yi Miyoko Christina — Chief Operations OfficerGrant/award (A): 45,000 (derivative) @ $0EDGAR
2022-11-234King-Jones Heidy — Chief Legal OfficerGrant/award (A): 90,000 (derivative) @ $0EDGAR
2022-11-234Leon Francisco — Chief Scientific OfficerGrant/award (A): 80,000 (derivative) @ $0EDGAR
2022-11-234Palmer Ashleigh — Director and CEO, DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR

Recent 8-K events — Provention Bio, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-04-278-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-248-K/A9.01 — Financial Statements and ExhibitsEDGAR
2023-03-138-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-168-K/A5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-02-138-K3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-02-028-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-058-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-068-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-188-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-038-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PRVB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs